Literature DB >> 16042363

Testosterone, aging and quality of life.

J E Morley1, M T Haren, M J Kim, R Kevorkian, H M Perry.   

Abstract

Testosterone levels decline over the lifespan. Many symptoms of hypogonadism are similar to age-related changes in older males. A small number of studies have suggested that some of these symptoms may be reversed by testosterone. Among them, one trial has suggested that decline in bioavailable testosterone may be related to the development of functional decline. Testosterone replacement during rehabilitation may improve functional outcomes and plays an important role in the maintenance of sexual related quality of life. The overall improvement in well-being and/or health-related quality of life in older males needs to be determined with large placebo-controlled trials. This is particularly important in view of the substantial placebo effect on aging symptomatology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16042363

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  8 in total

1.  Changes of pituitary and penile structure in male adult rats following castration and high-fat diet.

Authors:  Y L Lu; B R Jiang; F Z Xia; H L Zhai; Y Chen; J Yu; L J Zhao; N J Wang; J Qiao; L Z Yang
Journal:  J Endocrinol Invest       Date:  2010-04-30       Impact factor: 4.256

2.  Modulation of Leydig cell function by cyclic nucleotide phosphodiesterase 8A.

Authors:  Valeria Vasta; Masami Shimizu-Albergine; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-15       Impact factor: 11.205

Review 3.  Management of complications of androgen deprivation therapy in the older man.

Authors:  Supriya G Mohile; Karen Mustian; Kathryn Bylow; William Hall; William Dale
Journal:  Crit Rev Oncol Hematol       Date:  2008-10-25       Impact factor: 6.312

4.  How to define hypogonadism? Results from a population of men consulting for sexual dysfunction.

Authors:  G Rastrelli; G Corona; M Tarocchi; E Mannucci; M Maggi
Journal:  J Endocrinol Invest       Date:  2016-01-05       Impact factor: 4.256

5.  Serum testosterone level and related metabolic factors in men over 70 years old.

Authors:  Y-J Tang; W-J Lee; Y-T Chen; P-H Liu; M-C Lee; W H H Sheu
Journal:  J Endocrinol Invest       Date:  2007-06       Impact factor: 4.256

6.  Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohort.

Authors:  Michael S Okun; Samuel S Wu; Dana Jennings; Kenneth Marek; Ramon L Rodriguez; Hubert H Fernandez
Journal:  J Clin Mov Disord       Date:  2014-11-26

7.  Improving the annual monitoring rates of testosterone replacement therapy patients in primary care.

Authors:  Omar Hassoun; Matt Starostka; Heather Shearer; Angela Millar; Salman Hassoun; Chris Isles
Journal:  BMJ Open Qual       Date:  2022-08

Review 8.  Sarcopenia: etiology, clinical consequences, intervention, and assessment.

Authors:  T Lang; T Streeper; P Cawthon; K Baldwin; D R Taaffe; T B Harris
Journal:  Osteoporos Int       Date:  2009-09-25       Impact factor: 4.507

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.